These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15041356)

  • 41. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations.
    Andoh TF; Burdmann EA; Bennett WM
    Semin Nephrol; 1997 Jan; 17(1):34-45. PubMed ID: 9000548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of the switch to tacrolimus in liver transplantation.
    González-Pinto I; Alonso O; Loinaz C; Gómez R; Rodríguez-Cañete A; Rodríguez F; Pérez-Saborido B; Paseiro G; Moreno-González E
    Transplant Proc; 1999 Sep; 31(6):2425-6. PubMed ID: 10500653
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation.
    Zervos XA; Weppler D; Fragulidis GP; Torres MB; Nery JR; Khan MF; Pinna AD; Kato T; Miller J; Reddy KR; Tzakis AG
    Transplant Proc; 1998 Jun; 30(4):1405-6. PubMed ID: 9636568
    [No Abstract]   [Full Text] [Related]  

  • 44. Multifocal alopecia areata during systemic cyclosporine A therapy.
    Cerottini JP; Panizzon RG; de Viragh PA
    Dermatology; 1999; 198(4):415-7. PubMed ID: 10490301
    [No Abstract]   [Full Text] [Related]  

  • 45. Cyclosporine and tacrolimus: the mainstay of immunosuppressive therapy for solid organ transplantation.
    Testa G; Klintmalm GB
    Clin Liver Dis; 1997 Aug; 1(2):417-37, x. PubMed ID: 15562576
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term survival of renal graft complicated with Burkitt lymphoma.
    Nathanson S; Lucidarme N; Landman-Parker J; Deschênes G
    Pediatr Nephrol; 2002 Dec; 17(12):1066-8. PubMed ID: 12478360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac hypertrophy in liver transplant recipients: tacrolimus, cyclosporine or both?
    Therapondos G; Plevris JN; Dollinger MM; Hayes PC; Flapan AD
    Transplantation; 2003 Jul; 76(2):446-7; author reply 447-8. PubMed ID: 12883220
    [No Abstract]   [Full Text] [Related]  

  • 48. Experience with cyclosporine.
    Langone AJ; Helderman JH
    Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
    [No Abstract]   [Full Text] [Related]  

  • 49. [Neurological complications after liver transplantation].
    Casanova B; Gisbert C
    Rev Neurol; 1995; 23(123):1037-40. PubMed ID: 8556587
    [No Abstract]   [Full Text] [Related]  

  • 50. [Cyclosporine or sirolimus: what would be your choice by instinct?].
    Arazzi M
    G Ital Nefrol; 2012; 29(6):647. PubMed ID: 23229659
    [No Abstract]   [Full Text] [Related]  

  • 51. [Liver transplantation. Indications, results, pre- and postoperative care].
    Böker KH; Oldhafer K
    Internist (Berl); 1996 Mar; 37(3):250-63. PubMed ID: 8919942
    [No Abstract]   [Full Text] [Related]  

  • 52. Composite outcomes in renal transplantation using cyclosporine.
    Keown PA
    Transplant Proc; 2004 Mar; 36(2 Suppl):35S-39S. PubMed ID: 15041304
    [No Abstract]   [Full Text] [Related]  

  • 53. Improved graft survival after renal transplantation in the United States, 1988 to 1996.
    Sam R; Leehey DJ
    N Engl J Med; 2000 Jun; 342(24):1837-8. PubMed ID: 10866557
    [No Abstract]   [Full Text] [Related]  

  • 54. Impact of immunosuppressive therapy on hypertension.
    MacDonald AS
    Transplantation; 2000 Dec; 70(11 Suppl):SS70-6. PubMed ID: 11152235
    [No Abstract]   [Full Text] [Related]  

  • 55. [Advances in pediatric liver transplantation].
    Jara P; Hierro L; Frauca E; de la Vega A; Camarena C; Díaz MC
    An Esp Pediatr; 1997 Jun; Spec No 1():30-2. PubMed ID: 9382261
    [No Abstract]   [Full Text] [Related]  

  • 56. Discovery, development, and clinical trial strategies for immunosuppressive agents.
    Kahan BD
    Adv Nephrol Necker Hosp; 1996; 25():63-89. PubMed ID: 8717621
    [No Abstract]   [Full Text] [Related]  

  • 57. An overview of the first decade of cyclosporine.
    Stiller CR
    Transplant Proc; 1996 Aug; 28(4):2005-12. PubMed ID: 8769139
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cyclosporin in the treatment of chronic diseases of the liver (excluding transplantation)].
    Di Martino V; Cadranel JF; Erlinger S
    Gastroenterol Clin Biol; 1997; 21(5):400-11. PubMed ID: 9208017
    [No Abstract]   [Full Text] [Related]  

  • 59. Comment: drug-herb interaction.
    Cheng TO
    Ann Pharmacother; 2001 Jan; 35(1):124-5. PubMed ID: 11197574
    [No Abstract]   [Full Text] [Related]  

  • 60. [Demyelinization and occipital atrophy due to cyclosporin A].
    Landete Pascual L; Valero Merino C; Casanova Estruch B
    Neurologia; 1999 Nov; 14(9):459. PubMed ID: 10613020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.